Article
Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model.
Antimicrobial agents and chemotherapy - 1 Sept 2009
Entenza José M, Haldimann Andreas, Giddey Marlyse, Lociuro Sergio, Hawser Stephen, Moreillon Philippe
Abstract excerpt
Iclaprim is a novel diaminopyrimidine antibiotic that is active against methicillin-resistant Staphylococcus aureus (MRSA). However, it is known that the activity of diaminopyrimidines against S. aureus is antagonized by thymidine through uptake and conversion to thymidylate by thymidine kinase. Unlike with humans, for whom thymidine levels are low, thymidine levels in rodents are high, thus precluding the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
